Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell

Jonathan Hoggatt, Pratibha Singh, Tiffany A. Tate, Bin Kuan Chou, Shruti R. Datari, Seiji Fukuda, Liqiong Liu, Peter V. Kharchenko, Amir Schajnovitz, Ninib Baryawno, Francois E. Mercier, Joseph Boyer, Jason Gardner, Dwight M. Morrow, David T. Scadden, Louis Pelus

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Hematopoietic stem cell transplantation is a potential curative therapy for malignant and nonmalignant diseases. Improving the efficiency of stem cell collection and the quality of the cells acquired can broaden the donor pool and improve patient outcomes. We developed a rapid stem cell mobilization regimen utilizing a unique CXCR2 agonist, GROβ and the CXCR4 antagonist AMD3100. A single injection of both agents resulted in stem cell mobilization peaking within 15 min that was equivalent in magnitude to a standard multi-day regimen of granulocyte colony-stimulating factor (G-CSF). Mechanistic studies determined that rapid mobilization results from synergistic signaling on neutrophils, resulting in enhanced MMP-9 release, and unexpectedly revealed genetic polymorphisms in MMP-9 that alter activity. This mobilization regimen results in preferential trafficking of stem cells that demonstrate a higher engraftment efficiency than those mobilized by G-CSF. Our studies suggest a potential new strategy for the rapid collection of an improved hematopoietic graft. A new strategy for stem cell mobilization enables rapid collection of an improved hematopoietic graft in humans.

Original languageEnglish (US)
Pages (from-to)191-204.e10
JournalCell
Volume172
Issue number1-2
DOIs
StatePublished - Jan 11 2018

Fingerprint

Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cells
Stem cells
Granulocyte Colony-Stimulating Factor
Matrix Metalloproteinases
Stem Cells
Transplants
Hematopoietic Stem Cell Transplantation
Genetic Polymorphisms
Grafts
Neutrophils
Tissue Donors
Injections
Polymorphism
Therapeutics

Keywords

  • AMD3100
  • bone marrow transplantation
  • CXCR2
  • CXCR4
  • granulocyte colony-stimulating factor
  • hematopoiesis
  • hematopoietic stem cell mobilization
  • MMP-9
  • neutrophils
  • stem cell trafficking

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Hoggatt, J., Singh, P., Tate, T. A., Chou, B. K., Datari, S. R., Fukuda, S., ... Pelus, L. (2018). Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. Cell, 172(1-2), 191-204.e10. https://doi.org/10.1016/j.cell.2017.11.003

Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. / Hoggatt, Jonathan; Singh, Pratibha; Tate, Tiffany A.; Chou, Bin Kuan; Datari, Shruti R.; Fukuda, Seiji; Liu, Liqiong; Kharchenko, Peter V.; Schajnovitz, Amir; Baryawno, Ninib; Mercier, Francois E.; Boyer, Joseph; Gardner, Jason; Morrow, Dwight M.; Scadden, David T.; Pelus, Louis.

In: Cell, Vol. 172, No. 1-2, 11.01.2018, p. 191-204.e10.

Research output: Contribution to journalArticle

Hoggatt, J, Singh, P, Tate, TA, Chou, BK, Datari, SR, Fukuda, S, Liu, L, Kharchenko, PV, Schajnovitz, A, Baryawno, N, Mercier, FE, Boyer, J, Gardner, J, Morrow, DM, Scadden, DT & Pelus, L 2018, 'Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell', Cell, vol. 172, no. 1-2, pp. 191-204.e10. https://doi.org/10.1016/j.cell.2017.11.003
Hoggatt J, Singh P, Tate TA, Chou BK, Datari SR, Fukuda S et al. Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. Cell. 2018 Jan 11;172(1-2):191-204.e10. https://doi.org/10.1016/j.cell.2017.11.003
Hoggatt, Jonathan ; Singh, Pratibha ; Tate, Tiffany A. ; Chou, Bin Kuan ; Datari, Shruti R. ; Fukuda, Seiji ; Liu, Liqiong ; Kharchenko, Peter V. ; Schajnovitz, Amir ; Baryawno, Ninib ; Mercier, Francois E. ; Boyer, Joseph ; Gardner, Jason ; Morrow, Dwight M. ; Scadden, David T. ; Pelus, Louis. / Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. In: Cell. 2018 ; Vol. 172, No. 1-2. pp. 191-204.e10.
@article{addd3b4f75a5462abb988484ac7559e4,
title = "Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell",
abstract = "Hematopoietic stem cell transplantation is a potential curative therapy for malignant and nonmalignant diseases. Improving the efficiency of stem cell collection and the quality of the cells acquired can broaden the donor pool and improve patient outcomes. We developed a rapid stem cell mobilization regimen utilizing a unique CXCR2 agonist, GROβ and the CXCR4 antagonist AMD3100. A single injection of both agents resulted in stem cell mobilization peaking within 15 min that was equivalent in magnitude to a standard multi-day regimen of granulocyte colony-stimulating factor (G-CSF). Mechanistic studies determined that rapid mobilization results from synergistic signaling on neutrophils, resulting in enhanced MMP-9 release, and unexpectedly revealed genetic polymorphisms in MMP-9 that alter activity. This mobilization regimen results in preferential trafficking of stem cells that demonstrate a higher engraftment efficiency than those mobilized by G-CSF. Our studies suggest a potential new strategy for the rapid collection of an improved hematopoietic graft. A new strategy for stem cell mobilization enables rapid collection of an improved hematopoietic graft in humans.",
keywords = "AMD3100, bone marrow transplantation, CXCR2, CXCR4, granulocyte colony-stimulating factor, hematopoiesis, hematopoietic stem cell mobilization, MMP-9, neutrophils, stem cell trafficking",
author = "Jonathan Hoggatt and Pratibha Singh and Tate, {Tiffany A.} and Chou, {Bin Kuan} and Datari, {Shruti R.} and Seiji Fukuda and Liqiong Liu and Kharchenko, {Peter V.} and Amir Schajnovitz and Ninib Baryawno and Mercier, {Francois E.} and Joseph Boyer and Jason Gardner and Morrow, {Dwight M.} and Scadden, {David T.} and Louis Pelus",
year = "2018",
month = "1",
day = "11",
doi = "10.1016/j.cell.2017.11.003",
language = "English (US)",
volume = "172",
pages = "191--204.e10",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "1-2",

}

TY - JOUR

T1 - Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell

AU - Hoggatt, Jonathan

AU - Singh, Pratibha

AU - Tate, Tiffany A.

AU - Chou, Bin Kuan

AU - Datari, Shruti R.

AU - Fukuda, Seiji

AU - Liu, Liqiong

AU - Kharchenko, Peter V.

AU - Schajnovitz, Amir

AU - Baryawno, Ninib

AU - Mercier, Francois E.

AU - Boyer, Joseph

AU - Gardner, Jason

AU - Morrow, Dwight M.

AU - Scadden, David T.

AU - Pelus, Louis

PY - 2018/1/11

Y1 - 2018/1/11

N2 - Hematopoietic stem cell transplantation is a potential curative therapy for malignant and nonmalignant diseases. Improving the efficiency of stem cell collection and the quality of the cells acquired can broaden the donor pool and improve patient outcomes. We developed a rapid stem cell mobilization regimen utilizing a unique CXCR2 agonist, GROβ and the CXCR4 antagonist AMD3100. A single injection of both agents resulted in stem cell mobilization peaking within 15 min that was equivalent in magnitude to a standard multi-day regimen of granulocyte colony-stimulating factor (G-CSF). Mechanistic studies determined that rapid mobilization results from synergistic signaling on neutrophils, resulting in enhanced MMP-9 release, and unexpectedly revealed genetic polymorphisms in MMP-9 that alter activity. This mobilization regimen results in preferential trafficking of stem cells that demonstrate a higher engraftment efficiency than those mobilized by G-CSF. Our studies suggest a potential new strategy for the rapid collection of an improved hematopoietic graft. A new strategy for stem cell mobilization enables rapid collection of an improved hematopoietic graft in humans.

AB - Hematopoietic stem cell transplantation is a potential curative therapy for malignant and nonmalignant diseases. Improving the efficiency of stem cell collection and the quality of the cells acquired can broaden the donor pool and improve patient outcomes. We developed a rapid stem cell mobilization regimen utilizing a unique CXCR2 agonist, GROβ and the CXCR4 antagonist AMD3100. A single injection of both agents resulted in stem cell mobilization peaking within 15 min that was equivalent in magnitude to a standard multi-day regimen of granulocyte colony-stimulating factor (G-CSF). Mechanistic studies determined that rapid mobilization results from synergistic signaling on neutrophils, resulting in enhanced MMP-9 release, and unexpectedly revealed genetic polymorphisms in MMP-9 that alter activity. This mobilization regimen results in preferential trafficking of stem cells that demonstrate a higher engraftment efficiency than those mobilized by G-CSF. Our studies suggest a potential new strategy for the rapid collection of an improved hematopoietic graft. A new strategy for stem cell mobilization enables rapid collection of an improved hematopoietic graft in humans.

KW - AMD3100

KW - bone marrow transplantation

KW - CXCR2

KW - CXCR4

KW - granulocyte colony-stimulating factor

KW - hematopoiesis

KW - hematopoietic stem cell mobilization

KW - MMP-9

KW - neutrophils

KW - stem cell trafficking

UR - http://www.scopus.com/inward/record.url?scp=85041113078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041113078&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2017.11.003

DO - 10.1016/j.cell.2017.11.003

M3 - Article

VL - 172

SP - 191-204.e10

JO - Cell

JF - Cell

SN - 0092-8674

IS - 1-2

ER -